Skip to content

The Role of Computerized Training in Post-Traumatic Stress Disorder

The Role of Computerized Training in Post-Traumatic Stress Disorder

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02687555
Enrollment
80
Registered
2016-02-22
Start date
2016-02-29
Completion date
2019-05-31
Last updated
2019-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Traumatic Stress Disorder

Brief summary

The purpose of this study is to determine whether a computerized training, Cognitive Bias Modification targetting appraisals (CBM-App), can reduce dysfunctional appraisals of trauma in patients with Post-Traumatic Stress Disorder (PTSD), compared to a control condition. Other outcomes measured include symptoms of PTSD and trauma-relevant dysfunctional cognitions. Participants are recruited from inpatients with PTSD admitted to the Clinic for Psychosomatic Medicine and Psychotherapy, LWL University Clinic of Ruhr University of Bochum.

Interventions

BEHAVIORALCognitive Bias Modification of Appraisals (CBM-App)
BEHAVIORALPeripheral Vision Task (control condition)

Sponsors

Daimler und Benz Stiftung
CollaboratorUNKNOWN
Technische Universität Dresden
CollaboratorOTHER
Ruhr University of Bochum
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Primary diagnosis of Post-Traumatic Stress Disorder according to ICD-10 (F43.1), and DSM-5 (as assessed via Clinician Adminstered PTSD Scale for DSM-5) * motivated and willing to take part in the study (including questionnaire measures, computer training, filling out questionnaires after discharge) * aged 18-60 years, male or female * fluent in German

Exclusion criteria

* Substance abuse/ substance dependence currently or in the past six months * active suicidal thoughts or intentions * psychotic disorder (past or present) * learning disability/ intellectual impairment * red-green colour blindness

Design outcomes

Primary

MeasureTime frame
Dysfunctional trauma-related appraisals as measured using an open-ended ambiguous scenarios taskPost-intervention (~ 2 weeks post-baseline)

Secondary

MeasureTime frameDescription
Dysfunctional trauma-related appraisals as measured using an open-ended ambiguous scenarios taskBaseline, Mid-intervention (~1 week post-baseline), End of inpatient admission (~6 weeks post-baseline), 6 weeks post-discharge, 3 months post-discharge
Post-Traumatic Cognitions Inventory (PTCI)Baseline, Mid-intervention (~1 week post-baseline), Post-intervention (~2 weeks post-baseline), End of inpatient admission (~6 weeks post-baseline), 6 weeks post-discharge, 3 months post-dischargeThe PTCI (Foa et al., 1999) is administered asking participants to report on their experience of post-traumatic cognitions in the previous week.
PTSD Checklist for DSM-5 (PCL-5)Baseline, Mid-intervention (~1 week post-baseline), Post-intervention (~2 weeks post-baseline), End of inpatient admission (~6 weeks post-baseline), 6 weeks post-discharge, 3 months post-dischargeThe PCL-5 (Weathers et al., 2013; German version by Ehring, Knaevelsrud, Krüger & Schäfer) is administered asking participants to report on their experience of post-traumatic symptoms in the previous week.
Trauma Implicit Associations Test (IAT)Baseline, Post-intervention (~2 weeks post-baseline)As developed by Lindgren et al. (2013)
Intrusions QuestionnaireBaseline, Mid-intervention (~1 week post-baseline), Post-intervention (~2 weeks post-baseline), End of inpatient admission (~6 weeks post-baseline), 6 weeks post-discharge, 3 months post-dischargeThe intrusions questionnaire asks participants to report on the frequency and characteristics of intrusive memories of trauma in the preceding week

Other

MeasureTime frame
Hair Cortisol ConcentrationBaseline, End of inpatient admission (~6 weeks post-baseline), 3 months post-discharge
Participant Feedback Questionnaire3 months post-discharge

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026